Single-cell irradiation from [211At]astatine-labeled C215 monoclonal antibody: Improved estimates of radiosensitivity from measurements on cellular uptake and retention

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1219-1221

  Palm, Stig ^a,b   Bäck, Tom ^a   Claesson, Ingela ^a   Delle, Ulla ^a   Hultborn, Ragnar ^a   Lindegren, Sture ^a   Jacobsson, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Alpha particles; Astatine 211; Radioimmunotherapy; Radiosensitivity

Indexed keywords

ASTATINE 211; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C215; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG UPTAKE; HUMAN; HUMAN CELL; IRRADIATION; ISOTOPE LABELING; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

ADENOCARCINOMA; ALPHA PARTICLES; ANTIBODIES, MONOCLONAL; ASTATINE; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; ISOTOPE LABELING; LINEAR ENERGY TRANSFER; RADIATION TOLERANCE; ROTATION; SUSPENSIONS; TUMOR CELLS, CULTURED;

EID: 0038199621     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Crawford LM Jr: From the Food and Drug Administration. JAMA 287: 1640, 2002.
2. Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, Ballangrud ÅM, Hamacher KA, Ma D, Humm JL, Brechbiel MW, Molinet R and Scheinberg DA. Targeted α-particle immunotherapy for myeloid leukemia. Blood 100: 1233-1239, 2002.
3. Zalutsky MR, Akabani G, Friedman HS, Cokgor I, Coleman RE, Friedman AH, McLendon RE, Zhao XG, Alston KL and Bigner DD: Radioimmunotherapy of recurrent glioma patients using α-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody. J Nucl Med 42(5, suppl): 121P, 2001 [abstract].
4. Brenner DJ and Hall EJ: Microbeams: a potent mix of physics and biology. Summary of the 5th International Workshop on Microbeam Probes of Cellular Radiation Response. Radiat Prot Dosimetry 99: 283-286, 2002.
5. 213Bi-HuM195 (anti-CD33) in patients with leukemia. J Nucl Med 40: 1935-1946, 1999.
6. 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell lines. Anticancer Res 20: 1005-1012, 2000.
7. Lindegren S, Andersson H, Bäck T, Jacobsson L, Karlsson B and Skarnemark G: High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate. Nucl Med Biol 28: 33-39, 2001.
8. Lindegren S, Bäck T and Jensen HJ: Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields. Appl Radiat Isot 55: 157-160, 2001.
9. Palm S, Bäck T, Claesson I, Delle U, Hultborn R, Jacobsson L, Köpf I and Lindegren S. Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay. Anticancer Res 18: 1671-1676, 1998.
10. Kueng W, Silber E and Eppenberger U: Quantification of cells cultured on 96-well plates. Anal Biochem 182: 16-19, 1989.
11. Loevinger R, Budinger TF and Watson EE: MIRD Primer for Absorbed Dose Calculations, Revised. New York: The Society of Nuclear Medicine, 1991.
12. 211At]astato-2′-deoxyuridine in human cancer cells. Int J Radiat Biol 72: 79-90, 1997.
13. Larsen RH, Akabani G, Welsh P and Zalutsky MR: The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro. Radiat Res 149: 155-162, 1998.
14. Walicka MA, Vaidyanathan G, Zalutsky MR, Adelstein SJ and Kassis AI: Survival and DNA damage in chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211. Radiat Res 150: 263-268, 1998.
15. Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR and Bruland ØS: Exposure of human osteosarcoma and bone marrow cells to tumour-targeted α-particles and γ-irradiation: analysis of cell survival and microdosimetry. Int J Radiat Biol 76: 1129-1141, 2000.
16. Aurlien E, Kvinnsland Y, Larsen RH and Bruland ØS: Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an α-emitting radioimmunoconjugate and external γ-irradiation. Int J Radiat Biol 78: 133-142, 2002.
17. Yang Y, Olofsson M, Köpf I and Hultborn R: Growth and clonogenic assays compared for irradiated MCF-7 and Colo-205 cell lines. Anticancer Res 18: 53-59, 1998.